Apellis Pharmaceuticals (APLS) Treasury Shares: 2020-2024
- Apellis Pharmaceuticals' Treasury Shares fell 7.91% to $4.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $4.0 million, marking a year-over-year decrease of 7.91%. This contributed to the annual value of $4.0 million for FY2024, which is 7.91% down from last year.
- Per Apellis Pharmaceuticals' latest filing, its Treasury Shares stood at $4.0 million for Q4 2024, which was down 7.91% from $4.3 million recorded in Q4 2023.
- In the past 5 years, Apellis Pharmaceuticals' Treasury Shares registered a high of $4.3 million during Q4 2023, and its lowest value of $502,000 during Q4 2020.
- In the last 3 years, Apellis Pharmaceuticals' Treasury Shares had a median value of $4.0 million in 2024 and averaged $3.9 million.
- In the last 5 years, Apellis Pharmaceuticals' Treasury Shares soared by 191.59% in 2022 and then fell by 7.91% in 2024.
- Over the past 5 years, Apellis Pharmaceuticals' Treasury Shares (Quarterly) stood at $502,000 in 2020, then soared by 144.02% to $1.2 million in 2021, then skyrocketed by 191.59% to $3.6 million in 2022, then climbed by 20.41% to $4.3 million in 2023, then declined by 7.91% to $4.0 million in 2024.
- Its Treasury Shares was $4.0 million in Q4 2024, compared to $4.3 million in Q4 2023 and $3.6 million in Q4 2022.
